Ticker: CO, Company: Global Cord Blood Corp, Type: 20-F, Date: 2019-07-23, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20190723/20-F/1/000.htm SEC Original: a19-10484_120f.htm
FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@globalcordbloodcorp.com 48 th Floor, Bank of China

---

---

Webplus: CO/20190723/20-F/2_EX-4.32/000.htm SEC Original: a19-10484_1ex4d32.htm
Cordlife Group Limited 1 Yishun Industrial Street 1 Phone (65) 6238 0808 Find Out More Company Registration Number: 200102883E CONFIDENTIAL Global Cord Blood Corporation. 48 th 1 Garden Road, Central, Hong Kong S.A.R Members of the Board: Cordlife Group Limited (“CGL”) is a consumer healthcare group, incorporated in Singapore since 2001, is the first cord blood bank to be set

---

---

Webplus: CO/20190723/20-F/3_EX-12.1/000.htm SEC Original: a19-10484_1ex12d1.htm
Certification I, Ting Zheng, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 23, 2019 Ting Zheng Chief Executive Officer 1 EX-12.1 3 a19-10484_1ex12d1.htm EX-12.1

---

---

Webplus: CO/20190723/20-F/4_EX-12.2/000.htm SEC Original: a19-10484_1ex12d2.htm
Certification I, Albert Chen, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. July 23, 2019 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-12.2 4 a19-10484_1ex12d2.htm EX-12.2

---

---

Webplus: CO/20190723/20-F/5_EX-13.1/000.htm SEC Original: a19-10484_1ex13d1.htm
Certification GLOBAL CORD BLOOD CORPORATION July 23, 2019 Ting Zheng Chief Executive Officer July 23, 2019 Albert Chen Chief Financial Officer (Principal Financial Officer)

---

---

Webplus: CO/20190723/20-F/6_EX-15.1/000.htm SEC Original: a19-10484_1ex15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the Registration Statements (No. 333 -183143 and No. 333 – 213730) on Form F-3 of Global Cord Blood Corporation of our reports dated Our report on the Revenue from Contracts with Customers Financial Instruments – Overall (Subtopic 825-10), Recognition and Measurement

---

---

Webplus: CO/20190723/20-F/7_EX-15.2/000.htm SEC Original: a19-10484_1ex15d2.htm
通 商 律 師 事 務 所 Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel:(8610) 65693399 Fax: (8610) 65693838 Website: www.tongshang.com July 23 Global Cord Blood Corporation 48 th 1 Garden Road Central, Hong Kong S.A.R. Dear Sirs/Madams: Annual Report SEC We consent to the reference of our name under

---

Company Info:

Ticker: CO, Company: Global Cord Blood Corp, Type: 20-F, Date: 2019-07-23, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000